CAVALLO, F., MARTIN, F.A., BELLONE, M., HELTAI, S., GATTI, E., TORNAGHI,
P., FRESCHI, M., FORNI, G., DELLABONA, P. and CASORATI, G., Co-expression
of B7-1 and ICAM-1 on tumors is required for rejection and the
establishment of a memory response. Europ. J. Immunol., 25, 1154–1162
(1995).
CAYEUX, S., BECK, C., DORKEN, B. and BLANKENSTEIN, T., Coexpression of
interleukin-4 and B7.1 in murine tumor cells leads to improved tumor
rejection and vaccine effect compared to single gene transfectants and a
classical adjuvant. Hum. Gene Ther., 7, 525–529 (1996).
CHEN, L., MCGOWAN, P., ASHE, S., JOHNSTON, J., LI, Y., HELLSTRO ̈M, I. and
HELLSTRO ̈M, K.E., Tumor immunogenicity determines the effect of B7
costimulation on T cell-mediated tumor immunity. J. exp. Med., 179,
523–532 (1994).
CSERR, H.F. and KNOPF, P.M., Cervical lymphatics, the blood-brain barrier
and the immunoreactivity of the brain: a new view. Immunol. Today, 13,
507–512 (1992).
FREEMAN, G.J., DISTECHE, C.M., GRIBBEN, J.G., ADLER, D.A., FREEDMAN,
A.S., DOUGERY, J. and NADLER, L.M., The gene for B7, a costimulatory
signal for T-cell activation, maps to chromosomal region 3q13.3-3q21.
Blood, 79, 489–494 (1992).
GAKEN, J.A., and 13 OTHERS, Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of
established tumors. Hum. Gene Ther., 8, 477–488 (1997).
GATELY, M.K., DESAI, B.B., WOLITZKY, A.G., QUINN, P.M., DWYER, C.M.,
PODLASKI, F.J., FAMILLETTI, P.C., SINIGAGLIA, F., CHIZONNITE, R. and
GUBLER, U., Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol., 147, 874–882 (1991).
HATHCOCK, K.S., LASZIO, G., PUCILLO, C., LINSLEY, P. and HODES, R.J.,
Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression
and function. J. exp. Med., 180, 631–640 (1994).
HODGE, J.W., ABRAMS, S., SCHLOM, J. and KANTOR, J.A., Induction of
antitumor immunity by recombinant vaccinia viruses expressing B7-1 or
B7-2 costimulatory molecules. Cancer Res., 54, 5552–5555 (1994).
KIKUCHI, T., JOKI, T., SAITOH, S., HATA, Y., ABE, T., KATO, N., KOBAYASHI,
A., MIYAZAKI, T. and OHNO, T., Anti-tumor activity of interleukin-2-producing tumor cells and recombinant interleukin 12 against mouse
glioma cells located in the central nervous system. Int. J. Cancer, 80,
425–430 (1999).
KRUMMEL, M.F., and ALLISON, J.P., CD28 and CTLA-4 have opposing
effects on the response of T cells to stimulation. J. exp. Med., 182, 459–465
(1995).
NASTALA, C.L., EDINGTON, H.D., MCKINNEY, T.G., TAHARA, H., NALESNIK,
M.A., BRUNDA, M.J., GATELY, M.K., WOLF, S.F., SCHREIBER, R.D. and
STORKUS, W.J., Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J. Immunol., 153, 1697–
1706 (1994).
